INDEMNITY AGREEMENTIndemnity Agreement • September 9th, 2013 • Flexion Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , is made by and between FLEXION THERAPEUTICS, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
Flexion Therapeutics, Inc.Letter Agreement • September 9th, 2013 • Flexion Therapeutics Inc • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Agreement”) sets forth the terms of your continued employment as Chief Executive Officer (“CEO”) and President with Flexion Therapeutics, Inc. (the “Company”). This Agreement will become effective upon your acceptance by executing this Agreement and returning the executed Agreement to me. As of its effective date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated November 8, 2007 (the “Prior Agreement”), except that the terms of your Proprietary Information and Inventions Agreement executed on March 10, 2009 shall continue to apply.
August 28, 2013 Mr. Fred Driscoll Dear Fred:Letter Agreement • September 9th, 2013 • Flexion Therapeutics Inc • Pharmaceutical preparations
This letter agreement (the “Agreement”) sets forth the terms of your continued employment with Flexion Therapeutics, Inc. (the “Company”), in the full time position of Chief Financial Officer, reporting to Michael Clayman, Chief Executive Officer. This Agreement will become effective upon your execution below. As of its effective date this Agreement will replace and supersede in its entirety the letter agreement between you and the Company dated April 17, 2013 (the “Prior Agreement”), except that the terms of your Proprietary Information, Inventions, Non-Solicitation, and Non-Competition Agreement executed on April 25, 2013 shall continue to apply.
